1-3 of 3
Jean-Claude Bystryn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Changes in the Presence of Multiple Markers of Circulating Melanoma Cells Correlate with Clinical Outcome in Patients with Melanoma

Sandra R. Reynolds, Jeff Albrecht, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, Andrew Conrad, Anne Zeleniuch-Jacquotte, Jean-Claude Bystryn
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1497–1502.
Published: 01 April 2003
View article titled, Changes in the Presence of Multiple Markers of Circulating Melanoma Cells Correlate with Clinical Outcome in Patients with Melanoma
Open the PDF for Changes in the Presence of Multiple Markers of Circulating Melanoma Cells Correlate with Clinical Outcome in Patients with Melanoma in another window
Journal Articles

Vaccine-induced CD8+ T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma

Sandra R. Reynolds, Anne Zeleniuch-Jacquotte, Richard L. Shapiro, Daniel F. Roses, Matthew N. Harris, Dean Johnston, Jean-Claude Bystryn
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 657–662.
Published: 01 February 2003
View article titled, Vaccine-induced CD8+ T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma
Open the PDF for Vaccine-induced CD8+ T-cell Responses to MAGE-3 Correlate with Clinical Outcome in Patients with Melanoma in another window
Journal Articles

Double-Blind Trial of a Polyvalent, Shed-Antigen, Melanoma Vaccine

Jean-Claude Bystryn, Anne Zeleniuch-Jacquotte, Ruth Oratz, Richard L. Shapiro, Matthew N. Harris, Daniel F. Roses
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (7): 1882–1887.
Published: 01 July 2001
View article titled, Double-Blind Trial of a Polyvalent, Shed-Antigen, Melanoma Vaccine
Open the PDF for Double-Blind Trial of a Polyvalent, Shed-Antigen, Melanoma Vaccine in another window